Literature DB >> 27297446

Surgical and Oncologic Outcomes After Major Liver Surgery and Extended Hemihepatectomy for Colorectal Liver Metastases.

Inge Ubink1, Jennifer M J Jongen1, Maarten W Nijkamp1, Eelco F J Meijer1, Thomas T Vellinga1, Richard van Hillegersberg1, I Quintus Molenaar1, Inne H M Borel Rinkes1, Jeroen Hagendoorn2.   

Abstract

PURPOSE: To determine the surgical and oncologic outcomes after major liver surgery for colorectal liver metastases (CRLM) at a Dutch University Hospital. PATIENTS AND METHODS: Consecutive patients with CRLM who had undergone major liver resection, defined as ≥ 4 liver segments, between January 2000 and December 2015 were identified from a prospectively maintained database.
RESULTS: Major liver surgery was performed in 117 patients. Of these, 26 patients had undergone formal extended left or right hemihepatectomy. Ninety-day postoperative mortality was 8%. Major postoperative complications occurred in 27% of patients; these adverse events were more common in the extended hemihepatectomy group. Median disease-free survival was 11 months and median overall survival 44 months.
CONCLUSION: Major liver surgery, including formal extended hemihepatectomy, is associated with significant operative morbidity and mortality but can confer prolonged overall survival for patients with CRLM. Copyright Â
© 2016 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Colorectal cancer; Hepatectomy; Metastasis; Morbidity; Survival

Mesh:

Year:  2016        PMID: 27297446     DOI: 10.1016/j.clcc.2016.04.006

Source DB:  PubMed          Journal:  Clin Colorectal Cancer        ISSN: 1533-0028            Impact factor:   4.481


  5 in total

1.  Perioperative and Long-Term Outcome for Intrahepatic Cholangiocarcinoma: Impact of Major Versus Minor Hepatectomy.

Authors:  Xu-Feng Zhang; Fabio Bagante; Jeffery Chakedis; Dimitrios Moris; Eliza W Beal; Matthew Weiss; Irinel Popescu; Hugo P Marques; Luca Aldrighetti; Shishir K Maithel; Carlo Pulitano; Todd W Bauer; Feng Shen; George A Poultsides; Oliver Soubrane; Guillaume Martel; B Groot Koerkamp; Alfredo Guglielmi; Endo Itaru; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2017-07-25       Impact factor: 3.452

2.  Safety and Feasibility of Additional Tumor Debulking to First-Line Palliative Combination Chemotherapy for Patients with Multiorgan Metastatic Colorectal Cancer.

Authors:  Elske C Gootjes; Eric P van der Stok; Cornelis Verhoef; Henk M W Verheul; Tineke E Buffart; Lotte Bakkerus; Mariette Labots; Barbara M Zonderhuis; Jurriaan B Tuynman; Martijn R Meijerink; Peter M van de Ven; Cornelis J A Haasbeek; Albert J Ten Tije; Jan-Willem B de Groot; Mathijs P Hendriks; Esther van Meerten; Joost J M E Nuyttens; Dirk J Grunhagen
Journal:  Oncologist       Date:  2020-06-16

3.  Influence of diabetes on short-term outcome after major hepatectomy: an underestimated risk?

Authors:  Alexander Fischer; Juri Fuchs; Christos Stravodimos; Ulf Hinz; Adrian Billeter; Markus W Büchler; Arianeb Mehrabi; Katrin Hoffmann
Journal:  BMC Surg       Date:  2020-11-30       Impact factor: 2.102

4.  Impact of post-hepatectomy liver failure on morbidity and short- and long-term survival after major hepatectomy.

Authors:  Ruth Baumgartner; Stefan Gilg; Bergthor Björnsson; Kristina Hasselgren; Poya Ghorbani; Christina Sauter; Per Stål; Per Sandstöm; Ernesto Sparrelid; Jennie Engstrand
Journal:  BJS Open       Date:  2022-07-07

5.  Differences of intraoperative outcomes and postoperative complications between intrahepatic cholangiocarcinoma and colorectal liver metastasis in different surgical methods.

Authors:  Qichen Chen; Yiling Zheng; Jinghua Chen; Jianguo Zhou; Jianjun Zhao; Xinyu Bi; Zhiyu Li; Zhen Huang; Yefan Zhang; Jianxiong Wu; Liming Wang; Hong Zhao; Jianqiang Cai
Journal:  Transl Cancer Res       Date:  2021-09       Impact factor: 1.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.